Secured Vaccines AND/OR Expected Vaccine Supply

(% of Total Population)

Following the First Meeting of the Multilateral Leaders Taskforce (MLT) for Scaling COVID-19 Tools between World Health Organization (WHO), the World Bank Group (WBG), International Monetary Fund (IMF), and World Trade Organization (WTO), the IMF-WHO COVID-19 Vaccine Supply Tracker is being made available. It is a comprehensive database jointly established by the IMF and WHO to track the number of vaccine doses secured by countries and areas through different channels, including bilateral agreements with manufacturers, donations from other countries, multilateral agreements through the COVAX Facility, WBG, Asian Development Bank (ADB) or other institutions/sources. The tracker builds on the work of the IMF Staff Discussion Note – A Proposal to End the COVID-19 Pandemic (Agarwal and Gopinath, 2021).

This database draws information from the public domain, COVAX Global Vaccine Market Assessment, the United Nations Children’s Emergency Fund (UNICEF), Duke Global Health Innovation Center, Airfinity, Our World in Data, the World Bank Group, Asian Development Bank, and African Vaccine Acquisition Task Team (AVATT).

For detailed information regarding data compilation methodology, please see the methodology document here.

This data is preliminary and will be subject to revisions in collaboration with countries and areas, suppliers, immunization, health and financing partners. This tracker is updated every week to reflect latest developments. For additional information or inquiries, please contact vaccinetracker@imf.org.


The IMF and WHO accept no responsibility whatsoever for any inaccurate or incomplete information or data that may be included in this database, and expressly disclaims any liability for damages as a result of its use. The responsibility for the interpretation and use of the content lies with the user. The IMF and WHO assume no responsibility or liability for any consequence resulting directly or indirectly from any action or inaction users take based on or made in reliance on the information and data available in this database.

The designations employed and the presentation of the material in this IMF-WHO COVID-19 Vaccine Supply Tracker follow exclusively the institutional style and practice of the IMF, may be at variance with those used by WHO and do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.